Table 2 Descriptive data of the extracted teeth in the study and control group.
From: Radiographic predictors for MRONJ in oncologic patients undergoing tooth extraction
Characteristics | Oncologic group | Control | |||
|---|---|---|---|---|---|
Number of extracted teeth, n | 218 | 238 | |||
Development of osteonecrosis, n (%) | MRONJ+ | % | MRONJ− | % | NA |
63 | 29% | 155 | 71% | ||
Type of teeth, n (%) | |||||
Incisors and canines | 18 | 30% | 43 | 70% | 75 |
Premolars | 14 | 24% | 45 | 76% | 59 |
Molars | 31 | 32% | 67 | 68% | 104 |
Region, n (%) | |||||
Anterior maxilla | 8 | 27% | 22 | 73% | 34 |
Posterior maxilla | 22 | 26% | 63 | 74% | 87 |
Anterior mandible | 10 | 32% | 21 | 68% | 41 |
Posterior mandible | 23 | 32% | 49 | 68% | 76 |
Underlying dental disease, n (%)* | |||||
Nonapparent | 3 | 12% | 21 | 88% | 23 |
Periodontal disease | 3 | 20% | 12 | 80% | 31 |
Endodontic pathology | 17 | 31% | 38 | 69% | 62 |
Combined lesion | 40 | 32% | 84 | 68% | 122 |
Drug holiday > 60 days, n (%) | |||||
No | 20 | 36% | 35 | 64% | NA |
Yes | 43 | 26% | 120 | 74% | |
Antibiotic prophylaxis, n (%) | |||||
No | 4 | 50% | 4 | 50% | 225 |
Yes | 59 | 29% | 146 | 71% | 13 |
Antiseptic mouthwash, n (%) | |||||
No | 2 | 40% | 3 | 60% | 9 |
Yes | 61 | 29% | 147 | 71% | 229 |
Use of L-PRF, n (%) | |||||
No | 18 | 38% | 29 | 62% | 228 |
Yes | 45 | 27% | 122 | 73% | 10 |
MRONJ worse stage, n (%) | |||||
Stage 1 | 32 | 51% | NA | NA | |
Stage 2 | 28 | 44% | NA | NA | |
Stage 3 | 3 | 5% | NA | NA | |
